Compumedics Statistics

Total Valuation

Compumedics has a market cap or net worth of AUD 60.93 million. The enterprise value is 72.32 million.

Market Cap	60.93M
Enterprise Value	72.32M

Important Dates

The last earnings date was Sunday, February 22, 2026.

Earnings Date	Feb 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Compumedics has 199.76 million shares outstanding. The number of shares has increased by 14.75% in one year.

Current Share Class	199.76M
Shares Outstanding	199.76M
Shares Change (YoY)	+14.75%
Shares Change (QoQ)	+39.90%
Owned by Insiders (%)	53.77%
Owned by Institutions (%)	2.95%
Float	71.99M

Valuation Ratios

The trailing PE ratio is 539.18 and the forward PE ratio is 20.33.

PE Ratio	539.18
Forward PE	20.33
PS Ratio	1.04
PB Ratio	2.61
P/TBV Ratio	2.61
P/FCF Ratio	14.08
P/OCF Ratio	13.94
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.19, with an EV/FCF ratio of 16.71.

EV / Earnings	639.99
EV / Sales	1.24
EV / EBITDA	16.19
EV / EBIT	23.62
EV / FCF	16.71

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.57.

Current Ratio	1.15
Quick Ratio	0.61
Debt / Equity	0.57
Debt / EBITDA	3.00
Debt / FCF	3.10
Interest Coverage	2.09

Financial Efficiency

Return on equity (ROE) is 0.50% and return on invested capital (ROIC) is 0.59%.

Return on Equity (ROE)	0.50%
Return on Assets (ROA)	3.75%
Return on Invested Capital (ROIC)	0.59%
Return on Capital Employed (ROCE)	12.05%
Weighted Average Cost of Capital (WACC)	4.55%
Revenue Per Employee	334,229
Profits Per Employee	646
Employee Count	175
Asset Turnover	1.15
Inventory Turnover	1.93

Taxes

In the past 12 months, Compumedics has paid 1.58 million in taxes.

Income Tax	1.58M
Effective Tax Rate	93.31%

Stock Price Statistics

The stock price has increased by +19.61% in the last 52 weeks. The beta is 0.21, so Compumedics's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+19.61%
50-Day Moving Average	0.35
200-Day Moving Average	0.32
Relative Strength Index (RSI)	37.23
Average Volume (20 Days)	54,566

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Compumedics had revenue of AUD 58.49 million and earned 113,000 in profits. Earnings per share was 0.00.

Revenue	58.49M
Gross Profit	31.24M
Operating Income	3.06M
Pretax Income	1.69M
Net Income	113,000
EBITDA	3.52M
EBIT	3.06M
Earnings Per Share (EPS)	0.00

Full Income Statement

Balance Sheet

The company has 2.00 million in cash and 13.40 million in debt, giving a net cash position of -11.39 million or -0.06 per share.

Cash & Cash Equivalents	2.00M
Total Debt	13.40M
Net Cash	-11.39M
Net Cash Per Share	-0.06
Equity (Book Value)	23.37M
Book Value Per Share	0.12
Working Capital	4.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.37 million and capital expenditures -43,000, giving a free cash flow of 4.33 million.

Operating Cash Flow	4.37M
Capital Expenditures	-43,000
Free Cash Flow	4.33M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 53.42%, with operating and profit margins of 5.24% and 0.19%.

Gross Margin	53.42%
Operating Margin	5.24%
Pretax Margin	2.89%
Profit Margin	0.19%
EBITDA Margin	6.02%
EBIT Margin	5.24%
FCF Margin	7.40%

Dividends & Yields

Compumedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.75%
Shareholder Yield	-14.75%
Earnings Yield	0.19%
FCF Yield	7.10%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Compumedics has an Altman Z-Score of 2.04 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.04
Piotroski F-Score	6